Dowden Nathan J — SEC Form 4 filings
SEC reporting owner CIK 1873392. 12 Form 4 filings on record with FilingPulse; latest filed 2026-09-03.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-03-05 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 6 filings — 62,083 shares, $937,329 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
- Largest priced transaction: sale of 26,595 shares @ $16.26 ($432,419) in Entrada Therapeutics, Inc., filed 2024-08-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | President & COO | 12 | — | 9 legs · 62,083 sh · $937,329 | 24 |
Form 4 filings — Dowden Nathan J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-03 | 4 | Entrada Therapeutics, Inc. (TRDA) | Tax withholding (F): 2,528 @ $7.14 | EDGAR |
| 2026-05-04 | 4 | Entrada Therapeutics, Inc. (TRDA) | Option exercise (M): 15,000 @ $1.74 · Sale (S): 15,000 @ $15.33 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Entrada Therapeutics, Inc. (TRDA) | Sale (S): 3,116 @ $13.02 · Sale (S): 11,894 @ $13.05 | EDGAR |
| 2026-03-03 | 4 | Entrada Therapeutics, Inc. (TRDA) | Grant/award (A): 55,800 @ $0 · Tax withholding (F): 7,223 @ $11.66 · Tax withholding (F): 14,038 @ $11.76 · Grant/award (A): 83,200 (derivative) @ $0 | EDGAR |
| 2025-09-04 | 4 | Entrada Therapeutics, Inc. (TRDA) | Tax withholding (F): 1,746 @ $5.43 | EDGAR |
| 2025-03-04 | 4 | Entrada Therapeutics, Inc. (TRDA) | Grant/award (A): 60,800 @ $0 · Tax withholding (F): 5,144 @ $11.68 · Grant/award (A): 90,800 (derivative) @ $0 | EDGAR |
| 2024-09-30 | 4 | Entrada Therapeutics, Inc. (TRDA) | Sale (S): 847 @ $16 | EDGAR |
| 2024-09-10 | 4 | Entrada Therapeutics, Inc. (TRDA) | Sale (S): 399 @ $15.19 · Sale (S): 1,904 @ $15.07 | EDGAR |
| 2024-09-05 | 4 | Entrada Therapeutics, Inc. (TRDA) | Tax withholding (F): 483 @ $15.76 · Tax withholding (F): 156 @ $16.93 · Tax withholding (F): 15 @ $17.70 · Tax withholding (F): 983 @ $15.42 · Tax withholding (F): 171 @ $15.13 | EDGAR |
| 2024-08-20 | 4 | Entrada Therapeutics, Inc. (TRDA) | Option exercise (M): 20,000 @ $1.74 · Sale (S): 26,595 @ $16.26 · Sale (S): 502 @ $16.70 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2024-03-08 | 4 | Entrada Therapeutics, Inc. (TRDA) | Sale (S): 1,826 @ $12.32 | EDGAR |
| 2024-03-05 | 4 | Entrada Therapeutics, Inc. (TRDA) | Grant/award (A): 33,100 @ $0 · Grant/award (A): 60,000 @ $0 · Tax withholding (F): 343 @ $12.42 · Tax withholding (F): 409 @ $13.37 · Tax withholding (F): 1,486 @ $12.28 · Grant/award (A): 50,100 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1873392 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →